Safety and Performance Study of the CardioGard Cannula
Sponsored by CardioGard Medical Ltd.
About this trial
Last updated 12 years ago
Study ID
CLN0009
Status
Completed
Type
Interventional
Phase
Phase 2
Placebo
No
Accepting
50 to 85 Years
All Sexes
Trial Timing
Ended 12 years ago
What is this trial about?
The objective of the study is to collect additional information related to the safety and performance of the CardioGard Cannula during bypass procedures.
What are the participation requirements?
Inclusion Criteria
* AVR (Aortic Valve Replacement), AVR+CABG (Coronary Artery Bypass Surgery)
* Non pregnant female
Exclusion Criteria
* Contraindication for open heart surgery under bypass machine
* Emergency Operation